CDK1 and breast carcinoma: Research indicates that YBX1 can promote the stability of multiple oncogenic transcripts in breast cancer cells by binding to the 3′UTR region of mRNA.[35] Analysis using the Mapping Binding Sites of RNA Binding Proteins database identified several potential binding sites for YBX1 in the 3′UTR region of CDK1 (Figure S4I, Supporting Information).